Risultati della ricerca - Robin Lesley

Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study ( ACE ‐ LY ‐003)... Autoría: Paolo Strati, Richy Agajanian, Izidore S. Lossos, Morton Coleman, Robert Kridel, Andrew Wood, Robin Lesley, Chuan‐Chuan Wun, Deborah M. Stephens